Boosting the diagnostic power of amyloid-β PET using a data-driven spatially informed classifier for decision support
Abstract Background Amyloid-β (Aβ) PET has emerged as clinically useful for more accurate diagnosis of patients with cognitive decline. Aβ deposition is a necessary cause or response to the cellular pathology of Alzheimer’s disease (AD). Usual clinical and research interpretation of amyloid PET does...
Guardado en:
Autores principales: | Ashwin V. Venkataraman, Wenjia Bai, Alex Whittington, James F. Myers, Eugenii A. Rabiner, Anne Lingford-Hughes, Paul M. Matthews, for the Alzheimer’s Disease Neuroimaging Initiative |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/232b9cbd125145b38e07fa18b48eaefd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amyloid
Publicado: (1994) -
11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017) -
β-Barrels and Amyloids: Structural Transitions, Biological Functions, and Pathogenesis
por: Anna I. Sulatskaya, et al.
Publicado: (2021) -
Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: Rebecca M. Parodi-Rullán, et al.
Publicado: (2021) -
Spatial Patterns of Amyloid Deposition in Patients with Chronic Focal or Diffuse Traumatic Brain Injury Using 18F-FPYBF-2 PET
por: Ubukata S, et al.
Publicado: (2020)